The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Longer-term follow-up of patients (pts) receiving prophylactic tocilizumab (toci) for the reduction of cytokine release syndrome (CRS) in the phase 1/2 MajesTEC-1 study of teclistamab in relapsed/refractory multiple myeloma (RRMM).
 
Niels W.C.J. van de Donk
Consulting or Advisory Role - Adaptive Biotechnologies (Inst); Amgen (Inst); Bayer (Inst); Bristol Myers Squibb Foundation (Inst); Celgene (Inst); Janssen (Inst); MERCK (Inst); Novartis (Inst); Roche (Inst); SERVIER (Inst); Takeda (Inst)
Research Funding - Amgen (Inst); Bristol Myers Squibb Foundation (Inst); Celgene (Inst); Cellectis (Inst); Janssen (Inst); Novartis (Inst)
 
Alfred L. Garfall
Stock and Other Ownership Interests - Cabaletta Bio
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb/Celgene; CDR-Life; GlaxoSmithKline; Janssen Oncology; Novartis
Research Funding - crispr therapeutics (Inst); Janssen Oncology (Inst); Novartis (Inst); Tmunity Therapeutics, Inc. (Inst)
Patents, Royalties, Other Intellectual Property - Patent in the field of CAR T cell therapy
Travel, Accommodations, Expenses - Janssen
 
Lotfi Benboubker
No Relationships to Disclose
 
Katarina Uttervall
Consulting or Advisory Role - Janssen, BMS, Sanofi (Inst)
Speakers' Bureau - Janssen, BMS (Inst)
 
Kaz Groen
No Relationships to Disclose
 
Laura Rosiñol
Honoraria - Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Bristol Myers Squibb Foundation; GlaxoSmithKline; Janssen-Cilag; Sanofi; Takeda
 
Jeffrey V Matous
Consulting or Advisory Role - BeiGene; Pharmacyclics
 
Deeksha Vishwamitra
Employment - ohnson & Johnson
Stock and Other Ownership Interests - ohnson & Johnson
Travel, Accommodations, Expenses - ohnson & Johnson (Inst)
 
Caroline Hodin
Employment - Janssen Oncology
Stock and Other Ownership Interests - Janssen Oncology
Travel, Accommodations, Expenses - Janssen Oncology
 
Tara Stephenson
Employment - Janssen Oncology
Stock and Other Ownership Interests - Janssen Oncology
 
Keqin Qi
Employment - Janssen
Stock and Other Ownership Interests - Janssen
 
Athena Zuppa
Employment - JJ Innovative Medicine
Stock and Other Ownership Interests - JJ Innovative Medicine
Travel, Accommodations, Expenses - JJ Innovative Medicine (Inst)
 
Katherine Chastain
Employment - Janssen
Stock and Other Ownership Interests - Janssen
 
Maria-Victoria Mateos
Honoraria - Abbvie/Genentech; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Pfizer; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Kite, a Gilead company; Pfizer; Regeneron; Roche/Genentech; Stemline Therapeutics; Takeda